Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma

DOI: 10.1093/neuonc/now287

Keywords: cancer, checkpoint inhibitors, CSF-1R, dendritic cell vaccine, glioblastoma, immunotherapy, PD-1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text